Athenex is a global speciality oncology pharmaceutical company focused on the development and commercialization of next generation therapies for cancer diseases and supportive therapies. Athenex used New York State funding of $200 million dollars to create a High Pharmacy Oncology Manufacturing Facility. This was in addition to a $25 million investment to expand the sixth floor of the Conventus Building on the Buffalo Niagara Medical Campus.
- 300,000 sq. ft.
- $10M contract partnered with I&C
- Est. Completion 2020
U&S Services provided the integration solution for the Building Management System, Plant Control
System, and Energy Management System for the new facility in Dunkirk, NY. Stark’s Equipment division provided the Boilers for the new build as well.